Recent technological advances in glycobiology and glycochemistry are paving the way for a
new era in carbohydrate vaccine design. This is enabling greater efficiency in the …

Carbohydrates are abundantly expressed on the surface of both eukaryotic and prokaryotic
cells, often as post translational modifications of proteins. Glycoproteins are recognized by …

Advances in the synthesis of oligo-or polysaccharides and new technologies developed in
glycobiology studies have opened a new avenue in carbohydrate vaccine design. In …

The glycocalyx, a thick layer of carbohydrates, surrounds the cell wall of most bacterial and
parasitic pathogens. Recognition of these unique glycans by the human immune system …

Carbohydrate antigens have shown promise as important targets for developing effective
vaccines and pathogen detection strategies. Modifying purified microbial glycans through …

Carbohydrates are regarded as promising targets for vaccine development against
infectious disease because cell surface glycans on many infectious agents are attributed to …

Vaccination is one of the greatest achievements in biomedical research preventing death
and morbidity in many infectious diseases through the induction of pathogen‐specific …

Vaccination is the most cost-efficient and the most powerful medical intervention in the
control, prevention and eradication of many diseases that affect human population. Capsular …

Are there general rules to obtain efficient immunization against carbohydrate antigens?
Thanks to technological advances in glycobiology and glycochemistry we entered a new era …

The development of carbohydrate-based anticancer vaccines is of high current interest.
Herein, the latest development in this exciting field is reviewed. After a general introduction …